IN2014DN10077A - - Google Patents

Download PDF

Info

Publication number
IN2014DN10077A
IN2014DN10077A IN10077DEN2014A IN2014DN10077A IN 2014DN10077 A IN2014DN10077 A IN 2014DN10077A IN 10077DEN2014 A IN10077DEN2014 A IN 10077DEN2014A IN 2014DN10077 A IN2014DN10077 A IN 2014DN10077A
Authority
IN
India
Prior art keywords
carbon content
organic carbon
less
during
total organic
Prior art date
Application number
Inventor
Kazuhiro Obae
Masayuki Kakizawa
Mitsuo Yamashita
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Publication of IN2014DN10077A publication Critical patent/IN2014DN10077A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/12—Powdering or granulating
    • C08J3/122—Pulverisation by spraying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02—Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates
    • C08K5/053—Polyhydroxylic alcohols
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/09—Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • C08K5/098—Metal salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/20—Carboxylic acid amides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/02—Cellulose; Modified cellulose
    • C08L1/04—Oxycellulose; Hydrocellulose, e.g. microcrystalline cellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
    • C08J2301/04—Oxycellulose; Hydrocellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

This cellulose powder has: an average degree of polymerization of 100 to 300; a weight average particle size of over 30 µm, but less than 250 µm; an apparent specific volume of 2.0 cm/g to less than 4.0 cm/g; and an organic carbon content from residual impurities , which is defined by the total organic carbon content (%) during 1% NaOH extraction to the total organic carbon content (%) during pure water extraction , of 0.002 to 0.060%.
IN10077DEN2014 2012-05-31 2013-05-30 IN2014DN10077A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012124016 2012-05-31
PCT/JP2013/065111 WO2013180246A1 (en) 2012-05-31 2013-05-30 Cellulose powder

Publications (1)

Publication Number Publication Date
IN2014DN10077A true IN2014DN10077A (en) 2015-08-21

Family

ID=49673433

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10077DEN2014 IN2014DN10077A (en) 2012-05-31 2013-05-30

Country Status (3)

Country Link
JP (3) JP6210981B2 (en)
IN (1) IN2014DN10077A (en)
WO (1) WO2013180246A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013180246A1 (en) * 2012-05-31 2013-12-05 旭化成ケミカルズ株式会社 Cellulose powder
JP5950012B1 (en) * 2015-09-17 2016-07-13 王子ホールディングス株式会社 Method for producing fine fibrous cellulose-containing material
JP6638290B2 (en) * 2015-09-30 2020-01-29 日本製紙株式会社 Powdered cellulose
BR112021011263A2 (en) * 2018-12-27 2021-08-31 Asahi Kasei Kabushiki Kaisha CELLULOSE POWDER, USE OF IT, AND TABLETS
JP6884920B2 (en) * 2019-04-02 2021-06-09 旭化成株式会社 How to improve the storage stability of tablets
EP4056638A4 (en) 2019-11-07 2022-11-30 Asahi Kasei Kabushiki Kaisha Cellulose composition, tablet, and orally disintegrating tablet

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5420126A (en) * 1977-07-12 1979-02-15 Asahi Chem Ind Co Ltd Pharmaceutical composition
JP3534130B2 (en) * 1994-03-01 2004-06-07 旭化成ケミカルズ株式会社 Pharmaceutical composition
KR100496749B1 (en) * 2000-07-05 2005-06-22 아사히 가세이 가부시키가이샤 Cellulose powder
CA2527686C (en) * 2003-05-30 2009-11-03 Asahi Kasei Chemicals Corporation Cellulose powder
JP2005232260A (en) * 2004-02-18 2005-09-02 Asahi Kasei Chemicals Corp Cellulose inorganic compound porous composite particles
CN101203553B (en) * 2005-04-22 2011-05-18 旭化成化学株式会社 Porous cellulose aggregate and molding composition thereof
WO2009157564A1 (en) * 2008-06-26 2009-12-30 旭化成ケミカルズ株式会社 Cellulose composition
JP5430091B2 (en) * 2008-07-09 2014-02-26 旭化成せんい株式会社 Superabsorbent resin and method for producing the same
CN102958980B (en) * 2010-06-29 2015-05-27 旭化成化学株式会社 Composite particles containing cellulose and inorganic compounds
US9358417B2 (en) * 2011-06-06 2016-06-07 Trudell Medical International Oscillating positive expiratory pressure device
WO2013180249A1 (en) * 2012-05-31 2013-12-05 旭化成ケミカルズ株式会社 Cellulose powder
WO2013180248A1 (en) * 2012-05-31 2013-12-05 旭化成ケミカルズ株式会社 Cellulose powder
WO2013180246A1 (en) * 2012-05-31 2013-12-05 旭化成ケミカルズ株式会社 Cellulose powder
JP6413940B2 (en) * 2015-06-11 2018-10-31 株式会社デンソー Driving assistance device

Also Published As

Publication number Publication date
JP6383835B2 (en) 2018-08-29
JP2017165972A (en) 2017-09-21
JP2018172699A (en) 2018-11-08
WO2013180246A1 (en) 2013-12-05
JP6210981B2 (en) 2017-10-11
JPWO2013180246A1 (en) 2016-01-21

Similar Documents

Publication Publication Date Title
IN2014DN10072A (en)
IN2014DN10076A (en)
IN2014DN10077A (en)
MX363137B (en) Methods for increasing the extractable rubber content of non-hevea plant matter.
CA3073378C (en) Rubber composition comprising a farnesene polymer and tire
IN2014CN02317A (en)
MX364734B (en) Processes for recovering rubber from aged briquettes and aged briquettes containing plant matter from non-hevea plants.
PH12013500083A1 (en) Method for producing hydraulic powder
EP4234483A3 (en) Synthesis and hydrogen storage properties of novel metal hydrides
EP3838930A3 (en) Polymerisation process
MX2013010889A (en) Process for preparing self-binding pigment particles.
MX2020008008A (en) Process for bacterially devulcanizing sulphur-vulcanized rubber particles.
IN2015MN00013A (en)
WO2015145054A3 (en) Implantable biocompatible reactor
Mikulevicius On the rate of convergence of simple and jump-adapted weak Euler schemes for Lévy driven SDEs
MY175060A (en) Method for processing rubber granules or rubber powders
MY163074A (en) Formulations comprising methylthioninium chloride
MX2012010850A (en) Continuous process for preparing polyfluoroacrylate particles.
GB201008401D0 (en) Novel process
MY162164A (en) Process for production of polymer nanocomposites
MX2012014199A (en) Iron (iii) caseinsuccinylate and method for the preparation thereof.
CA2836488C (en) Methods for treating obesity and/or metabolic syndrome
IN2012DN06607A (en)
MY171853A (en) Sphingomyelin-containing supplement
PT2928927T (en) Process to produce polyvinyl-ester compositions with low residual monomer content